Global BioAccess Fund
Sonia Gulati has an extensive background in the life sciences industry, with experience in investment management and company leadership roles. Currently serving as the Principal at Global BioAccess Fund, Sonia oversees funding for early-stage companies in the medical field. Additionally, Sonia holds various director positions in different companies including TigaTx, 1200 Pharma, Pinpoint Therapeutics, GLS Therapeutics, NuvoNuro, Actinobac Biomed, Inc., and NeuroNovus Therapeutics. Previously, Sonia worked as an Executive in Residence at Kairos Ventures and as an Assistant Director at New York Ventures. Gulati holds a Doctor of Philosophy (PhD) from Columbia University Graduate School of Arts and Sciences and a Bachelor of Arts (B.A.) from Barnard College, Columbia University.
This person is not in any teams
Global BioAccess Fund
At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.